POTASSIUM CITRATE
RISING · POTASSIUM CITRATE
Open FDA's page for this record- Application number
- ANDA077440
- Sponsor name
- RISING
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20060608
- Submission type
- SUPPL
- Submission number
- 5
- Submission status
- AP
- Submission status date
- 20240530
- Review priority
- UNKNOWN
- Submission class code
- MANUF (CMC)
- Submission class code description
- Manufacturing (CMC)
- Products
- Product number
- 002
- Reference drug
- No
- Brand name
- POTASSIUM CITRATE
- Reference standard
- No
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- POTASSIUM CITRATE
- Strength
- 10MEQ
- Product number
- 001
- Reference drug
- No
- Brand name
- POTASSIUM CITRATE
- Reference standard
- No
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- POTASSIUM CITRATE
- Strength
- 5MEQ
- Harmonized identifiers (openFDA)
- Application number
- ANDA077440
- Brand name
- POTASSIUM CITRATE
- Generic name
- POTASSIUM CITRATE
- Manufacturer name
- Rising Pharma Holdings, Inc.
- Product NDC
- 16571-864, 16571-865
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- POTASSIUM CITRATE
- RxCUI
- 199376, 199381
- SPL ID
- 73e193b2-7b67-4a83-9f5c-9b20ae32e779
- SPL set ID
- 164d9d05-fbb1-4d99-8ba3-ff9c172aa8ca
- Package NDC
- 16571-864-01, 16571-865-01
- UNII
- EE90ONI6FF